PRELUDE CAPITAL MANAGEMENT, LLC - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 92 filers reported holding SPERO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$8,000
+166.7%
10,726
+3475.3%
0.00%
Q3 2020$3,000
+200.0%
300
+200.0%
0.00%
Q2 2020$1,000
-83.3%
100
-85.7%
0.00%
Q1 2020$6,000
-33.3%
700
-22.2%
0.00%
Q4 2019$9,000
+28.6%
900
+28.6%
0.00%
Q3 2019$7,000
+16.7%
700
+40.0%
0.00%
Q2 2019$6,0005000.00%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders